👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Zai Lab Down But JPMorgan Says Weakness 'Overdone'

Published 12/15/2021, 01:55 PM
Updated 12/15/2021, 01:57 PM
© Reuters.
ZLAB
-

By Sam Boughedda

Investing.com — Zai Lab Ltd (NASDAQ:ZLAB) shares have fallen 18% Wednesday, with JPMorgan saying it is in response to media articles concerning the H.R. 1155 bill, which imposes restrictions related to China's Xinjiang Uyghur region.

The bill, which has been passed in the House and will go to the Senate, includes the prohibition of certain imports from Xinjiang and imposing sanctions on those responsible for human rights violations, in response to human rights violations. 

Biopharmaceutical company Zai Labs is headquartered in Shanghai, China. 

JPMorgan analyst Anupam Rama earlier in the day added the stock to the firm's Analyst Focus List, saying the 50% decline for the year-to-date has created a "valuation disconnect." 

Rama talked with company executives at Zai. The company said it has no reason to believe it will be affected by the bill, which has led the analyst to say that weakness in ZLAB shares is "materially overdone."

Rama reiterated an overweight rating and $136 price target on the stock.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.